DFP – Neuroprogressive and Dementia Network

Alzheimer’s Disease Research

The Deep & Frequent Phenotyping (DFP) study is designed to explore how we can detect Alzheimer’s disease before symptoms appear. The study aims to build a detailed database using a variety of tests and assessments from individuals who may be at risk. These include brain scans, cognitive and memory tests, retinal imaging, blood tests, and wearable devices that track daily activities.
Led by the University of Oxford, the study recruited participants over the age of 60 from across the UK, with our site located in Edinburgh. The DFP study hopes to help improve the design and effectiveness of future clinical trials.

Findings from the study will be made available through the Dementias Platform UK Data Portal.

This study is closed to recruitment

To find out more about this research study, please contact:
loth.sdcrn@nhs.scot
0131 537 3804

Key Staff

NDN Principle Investigator: Dr Catherine Pennington

NDN Study Lead: Marian Montanha

This is looking at patients with Alzheimer’s Disease and Healthy individuals.

CONTACT INFORMATION

Neuroprogressive & Dementia Research Network Office

Old Pharmacy Building
Western General Hospital
Edinburgh
EH4 2XU

Email: loth.sdcrn@nhs.scot

Telephone: 0131 537 3804

ABOUT US

The NRS Neuroprogressive Disease and Dementia Network team in NHS Lothian conduct commercial and investigator led studies for: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Motor Neurone Disease, dementia with Lewy bodies, Progressive Supranuclear Palsy and Multiple System Atrophy.